Mintz has added Melinda Roberts as a member of its Intellectual Property Practice in New York, continuing the firm’s expansion in life sciences and pharmaceutical patent litigation.
Roberts joins from Venable, where she was a partner in the Intellectual Property Litigation group. She represents pharmaceutical and biotechnology companies and patent owners in complex disputes, including Hatch-Waxman litigation and post-grant proceedings before the Patent Trial and Appeal Board.
Her experience covers biologics, small molecules and other life sciences technologies, with work extending from early case development through trial. She has handled disputes involving composition-of-matter, formulation and dosing regimen patents in federal court and before the patent board.
Roberts brings a scientific background to the practice. Before beginning her legal career, she conducted neuroscience research at Yale University School of Medicine. She holds a bachelor’s degree in chemistry from Yale University and earned her law degree from the University of Wisconsin Law School.
Mintz said the appointment adds depth to its life sciences patent litigation team as pharmaceutical and biotechnology clients address disputes involving the innovations underlying their businesses.
Roberts also identified biosimilars, beauty, women’s health and emerging life sciences companies as areas where she plans to expand her work using the firm’s platform.
The appointment brings together courtroom experience, administrative patent proceedings and technical training relevant to disputes over complex therapeutic products. It also extends Mintz’s New York intellectual property offering within a firm serving life sciences, private equity, energy and technology clients.
Mintz has more than 600 attorneys across offices in the United States and Canada, including Boston, New York, San Francisco, San Diego and Toronto.
KEY QUOTES:
“We have had great success in building a life sciences patent litigation team with the depth and range to handle our clients’ most consequential disputes. Melinda’s extensive experience in Hatch-Waxman and other complex pharmaceutical patent disputes adds further depth to an already formidable team, positioning us to continue growing alongside our clients.”
Bob Bodian, Managing Partner Of Mintz
“The strength of Mintz’s Life Sciences practice was a major factor in my decision to join, along with the entrepreneurial spirit and energy I saw across the team. I’m excited to continue serving major pharmaceutical companies and patent owners, while building on Mintz’s platform to expand my work in areas like biosimilars, beauty, and women’s health, as well as with emerging life sciences companies.”
Melinda Roberts, Member Of Mintz’s Intellectual Property Practice
